WHO says China group talked with Wuhan researchers over infection sources Kumar Jeetendra | August 4, 2020 A World Health Organization team in China to research the roots of COVID-19 had”extensive discussions” and exchanges with scientists in Wuhan in which the outbreak was first detected, a spokesman said on Tuesday. The talks included updates on animal health study, he said. China shut down a wildlife market in Wuhan in the start of …
Disposed PPE could be transformed into biofuel, says Indian researchers Kumar Jeetendra | August 4, 2020 Indian scientists have suggested a method to convert the plastic used in personal protective equipment (PPE) into renewable liquid fuels, an advance that could help mitigate the problem of dumped PPE, now being disposed of unprecedented levels because of this COVID-19 pandemic. According to the study, published in the journal Biofuels, billions of items of …
US researchers discover conceivable COVID-19 treatment Kumar Jeetendra | August 4, 2020 Researchers in the US have found a potential therapeutic treatment for SARS-CoV-2, the virus which causes COVID-19, along with other coronaviruses. Pathogenic coronaviruses are a major threat to international public health, as shown by the SARS-CoV, MERS-CoV, along with the recently emerged SARS-CoV-2. All these coronavirus 3C-like proteases, called 3CLpro, are strong therapeutic targets because …
Lupin dispatches COVID-19 medication Favipiravir in India at Rs 49 for each tablet Kumar Jeetendra | August 5, 2020 Drug major Lupin on Wednesday announced the launch of its Favipiravir medication under the brand name’Covihalt’ for its treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per pill in India. Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing. Its …
Normal cold contamination may prepare the body to perceive novel coronavirus: Study Kumar Jeetendra | August 5, 2020 The body fight it off, also identifies some parts of the novel coronavirus, according to a study whose findings might explain why some individuals have milder COVID-19 cases than others. The research, published in the journal Science, noted that the immune system’s memory T cells keep track of the viruses they’ve seen previously, giving the …
The need to combat antimicrobial resistance Kumar Jeetendra | August 5, 2020 With over 700,000 people losing the battle to antimicrobial resistance (AMR) every year and an additional 10 million projected mortality by 2050, antimicrobial resistance (AMR) is globally, one of the major causes of public health concern. Amongst the several types of AMR, antibacterial resistance (ABR) is currently posing serious challenges to medical science. Facets driving …
Thermo Fisher Scientific Launches Exclusive Website for its Chemical Business Offerings in India Kumar Jeetendra | August 5, 2020 Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new website for its chemicals business offerings. This website will serve as a dedicated platform towards an extensive range of Laboratory and Production chemicals. The new website will bring all major chemical brands from Thermo Fisher Scientific including Alfa Aesar, Acros …
Working together with govt organizations to create treatment for COVID-19: Cipla Kumar Jeetendra | August 5, 2020 Medication major Cipla is working together with government agencies to come up with a treatment for COVID-19 while ramping up the production of various life saving essential drugs, according to company’s chairman YK Hamied. Sharing information with business’s shareholders at the drug firm’s annual report for 2019-20, Hamied said the company is at the forefront …
BioNTech, Fosun Pharmaceutical dispatch another COVID-19 vaccine trial Kumar Jeetendra | August 5, 2020 Germany’s BioNTech and China’s Shanghai Fosun Pharmaceutical on Wednesday declared the start of another COVID-19 vaccine trial in China with a total of 144 participants. “The study is designed to support the regulatory approval process for the Chinese market and plans to confirm the safety and immunogenicity profile observed in participants in the German and …
BDR Pharmaceuticals dispatches Favipiravir at Rs 63 for each tablet in India Kumar Jeetendra | August 5, 2020 Drug firm BDR Pharmaceuticals on Wednesday said it has established its antifungal medication Favipiravir for treating COVID-19 patients in India at a cost of Rs 63 each tablet. The business has also come up with a patient assistance programme which will allow patients and institutions who have limited resources to buy the medicine at an …
Quicker Test for Covid-19 Antibodies Kumar Jeetendra | August 5, 2020 A team of Swiss-German researchers has developed a method of testing for neutralizing antibodies against SARS-CoV-2 that creates a result in half the time of traditional tests. A conventional neutralization test to determine immunity to SARS-CoV-2 usually takes two to three days and has to be carried out with infectious coronaviruses in a lab resorting …
UCI researchers develop novel molecule for COVID-19 treatment Kumar Jeetendra | August 6, 2020 When the coronavirus pandemic struck, nearly everyone in the University of California, Irvine — and colleges across the country — had to abandon campus. That’s because his laboratory, which designs and constructs chemical molecules, had the ideal equipment to aid in the international push to locate remedies for COVID-19. Nowick’s group set to work in …
